Duration of therapy for tuberculosis in patients infected with Human Immunodeficiency Virus
Editorial Group: Cochrane HIV/AIDS Group
Published Online: 22 JUL 2002
Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
How to Cite
Pai M, Reingold AL, Riley LW, Colford JM, Ojubolamo O, Mthiyane T. Duration of therapy for tuberculosis in patients infected with Human Immunodeficiency Virus (Protocol). Cochrane Database of Systematic Reviews 2002, Issue 3. Art. No.: CD003821. DOI: 10.1002/14651858.CD003821.
- Publication Status: Edited (no change to conclusions)
- Published Online: 22 JUL 2002
This is the protocol for a review and there is no abstract. The objectives are as follows:
The aim of our systematic review is to assess the effects of an extended duration of the standard short course anti-tuberculosis chemotherapy (more than 6 months) on recurrence, cure, mortality, treatment failure, and adverse events in HIV-infected patients, using all available randomized controlled trials.